The Canadian energy producer reported $0.82 EPS and $429.6M revenue, exceeding forecasts amid 10% production growth. Peyto Exploration posted first-quarter GAAP earnings per share of $0.82, surpassing estimates by $0.28. Revenue reached $429.6M, up 21.3% year-over-year and
QuickLogic targets 50-100% revenue growth in 2026 QuickLogic aims to achieve 50% to 100% year-over-year revenue growth in 2026. The company's CEO, Brian C. Faith, stated that significant progress has been made toward this goal. The growth is expected to be driven
Key inflation and housing market indicators will be released, offering insights into pricing pressures and lending activity. The Bureau of Labor Statistics will release the Producer Price Index for final demand at 8:30 AM ET, a critical measure of inflation at the wholesal
SideChannel's Q2 revenue fell to $1.58 million SideChannel, Inc. reported a decline in total revenue for Q2 FY 2026, down to $1.58 million from $1.89 million in Q2 FY 2025. The 11.9% decline was largely due to a 28.4% year-over-year drop in vCISO services revenue.
Parks! America sets aside $500,000 for digital signage investments while flagging macroeconomic challenges in March quarter results. Parks! America Inc. (PRKA) announced plans to spend up to $0.5 million on digital signage, as outlined during its Q2 fiscal 2026 earnings ca
The firm reported Q1 2026 revenue of nearly $241 million, up 15.7%, and raised its inorganic revenue outlook to $55M. Andersen Group Inc. revised its 2026 revenue forecast to $980 million, up from a prior range, after posting Q1 2026 revenue of nearly $241 million. The com
Nasdaq Futures cycle ending with a correction ahead Nasdaq Futures are approaching the end of their current cycle, which began at the March 31, 2026 low. The cycle is characterized as a five-wave impulse, with wave ((i)) concluding at 24,348.25, followed by a correcti
The company reported $255M-$257M revenue guidance for 2026 and opened nine new stores in Q1. Black Rock Coffee Bar reported a 24% year-over-year increase in Q1 2026 revenue and adjusted EBITDA, driven by strong operational performance. The company opened nine new locations
Verrica's Q1 YCANTH units rise 12.1% sequentially Verrica Pharmaceuticals saw a 12.1% sequential increase in dispensed YCANTH units in Q1 2026. The company is targeting the initiation of COVE-3 by mid-2026. Verrica's growth in market demand for YCANTH set new rec
The biotech firm reports $234 million in cash extending through 2029, supporting its upcoming RESCUE Phase 3 study. Relmada Therapeutics announced a $234 million cash runway, sufficient to fund operations through 2029. The funds will support the mid-2026 launch of its Phas
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.